Nuclear Cardiology

Single photon computed tomography (SPECT) and positron emission tomography (PET) molecular imaging are used as primary cardiac imaging modalities to evaluate the function of the heart. It uses radioactive isotopes attached to sugars that are metabolized by cardiomyocytes. This creates an image of the metabolic activity of the heart and shows areas of ischemia or infarct. Other radiotracers can image the heart to diagnosis cardiac amyloidosis and sarcoidosis.

Key trends in nuclear cardiology take center stage at ASNC 2025
Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology annual meeting, shared some key takeaways from the conference. “This is no longer just about imaging for coronary disease," he explained. "Nuclear cardiology now helps guide therapy across a wide range of conditions."
ASNC calls on members to fight 57% Medicare cut for cardiac amyloid imaging
Jamieson M. Bourque, MD, MHS, president-elect of the American Society of Nuclear Cardiology, shared the group's concerns with Cardiovascular Business. “This is going to have a highly negative impact," he said.
How nuclear cardiology has transformed care for cardiac amyloidosis
Prem Soman, MD, PhD, explained how early detection and new therapies have been game-changers for the treatment and diagnosis of cardiac amyloidosis.
Cardiology group thanks Taylor Swift for spreading word about nuclear stress testing
When Taylor Swift speaks, the world listens. And when she recently appeared on a podcast for the very first time, she shared the story of how a nuclear stress test saved her father's life.
Nuclear imaging company Positron moves to New York for ‘exciting new chapter’
Positron made the move to help its case when it files an official Form 10 registration statement with the SEC.

Video interview with Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology (ASNC) annual meeting, director of nuclear cardiology and a professor of medicine at Cleveland Clinic, shares some of the key highlights from the conference.

Key trends in nuclear cardiology take center stage at ASNC 2025

Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology annual meeting, shared some key takeaways from the conference. “This is no longer just about imaging for coronary disease," he explained. "Nuclear cardiology now helps guide therapy across a wide range of conditions."

American Society of Nuclear Cardiology (ASNC) President-elect Jamieson M. Bourque, MD, MHS, FASNC, medical director of nuclear cardiology, echocardiography, and the stress laboratory at UVA Health in Charlottesville, and a professor of medicine and radiology at the University of Virginia, said the society is fighting a major proposed cut in CMS reimbursements in 2026.

ASNC calls on members to fight 57% Medicare cut for cardiac amyloid imaging

Jamieson M. Bourque, MD, MHS, president-elect of the American Society of Nuclear Cardiology, shared the group's concerns with Cardiovascular Business. “This is going to have a highly negative impact," he said.

Prem Soman, MD, PhD, FACC, FRCP, past president of the American Society of Nuclear Cardiology (ASNC), the Richard S. Caligiuri Endowed Chair in Amyloidosis and Heart Failure, director of the Cardiac Amyloidosis Center, director of nuclear cardiology, and a professor of medicine, University of Pittsburgh Medical Center (UPMC) Heart and Vascular Institute. He is presenting the keynote Mario Verani Memorial Lecture at ASNC 2025, where he will discuss transforming cardiac amyloidosis care.

How nuclear cardiology has transformed care for cardiac amyloidosis

Prem Soman, MD, PhD, explained how early detection and new therapies have been game-changers for the treatment and diagnosis of cardiac amyloidosis.

Cardiology group thanks Taylor Swift for spreading word about nuclear stress testing

When Taylor Swift speaks, the world listens. And when she recently appeared on a podcast for the very first time, she shared the story of how a nuclear stress test saved her father's life.

Positron NeuSight PET-CT 64 slice scanner

Nuclear imaging company Positron moves to New York for ‘exciting new chapter’

Positron made the move to help its case when it files an official Form 10 registration statement with the SEC.

Greg Piefer, PhD, CEO and founder of Shine, explains the timeline to restart U.S. production of molybdenum-99 (Mo-99) for nuclear imaging.

Shine working toward U.S. production of Mo-99 for SPECT nuclear imaging

Greg Piefer, PhD, chief executive and founder of Shine, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first sustained U.S. commercial supplier of molybdenum-99 in decades.

Molecular Imaging PET and SPECT sign in GE booth ACC23.

Shine working toward U.S. production of Mo-99 for SPECT imaging

Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.

Suman Tandon, MD, FASNC, a cardiac imager at St. Francis Hospital and Heart Center, in Rosyln, New York, and an American Society of Nuclear Cardiology (ASNC) representative to the American Medical Association (AMA) House of Delegates (HOD), explains ASNC’s call on Congress for to reduce prior authorization, appropriate use mandates and to make Medicare payment reforms.

ASNC lobbies Congress to curb prior authorization, oppose AUC mandates and embrace payment reform

Suman Tandon, MD, an American Society of Nuclear Cardiology board member, explains the group's call on Congress to update a number of healthcare policies.